Blaze Bioscience, a company working on a fluorescent molecule to help surgeons better remove tumors, reported data from a phase 1 trial testing its “tumor paint” in adults with gliomas, a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results